^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CPO301

    i
    Other names: CPO301, SYS6010
    Associations

    News

    Trials
    Company:
    CSPC Pharma
    Drug class:
    EGFR-targeted antibody-drug conjugate
    Related drugs:
    Associations

    News

    Trials
    over1year
    A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors (clinicaltrials.gov)
    P1, N=102, Recruiting, Conjupro Biotherapeutics, Inc.
    New P1 trial • Metastases
    |
    EGFR (Epidermal growth factor receptor) • KRAS (KRAS proto-oncogene GTPase)
    |
    EGFR mutation • KRAS wild-type • RAS wild-type
    |
    CPO301